首页 | 本学科首页   官方微博 | 高级检索  
   检索      

熊去氧胆酸对阿霉素诱导的H9c2心肌细胞的影响及机制研究
引用本文:王 皓,夏薇薇,龙广凤,杨大恒,裴知音,陈红兵.熊去氧胆酸对阿霉素诱导的H9c2心肌细胞的影响及机制研究[J].现代生物医学进展,2021(3):418-423.
作者姓名:王 皓  夏薇薇  龙广凤  杨大恒  裴知音  陈红兵
作者单位:1 南京医科大学附属儿童医院检验科 江苏 南京 210008;2 南京医科大学江苏省儿科学重点实验室 江苏 南京 210008
基金项目:江苏省博士后科研基金项目(2018K255C)
摘    要:目的:探讨熊去氧胆酸(UDCA)对阿霉素(DOX)诱导的H9c2心肌细胞损伤的影响及机制。方法:体外培养H9c2细胞,1μM DOX和不同浓度UDCA处理H9c2,CCK-8法测定细胞活力;实时定量聚合酶链反应检测心肌细胞凋亡分子Bax及炎症因子IL-1β、IL-6的表达;Western blotting检测UDCA对DOX诱导的心肌细胞凋亡相关蛋白Bax、Bcl2、Caspase3表达水平变化。结果:与对照组相比,DOX组心肌细胞活力减弱;炎症因子IL-1β,IL-6表达上调;促凋亡分子Bax和cleaved Caspase3表达增多;抑制凋亡蛋白Bcl2下调(P<0.05)。与DOX组相比,UDCA+DOX组显著恢复心肌细胞活力;炎症因子IL-1β、IL-6表达下调;促凋亡分子Bax、cleaved Caspase3下调;抑制凋亡蛋白Bcl2表达上调(P<0.05)。结论:UDCA能缓解DOX诱导的H9c2心肌细胞损伤,其机制可能与抑制炎症及凋亡有关。本研究为阿霉素心肌毒性的防治提供新的实验基础及理论依据。

关 键 词:熊去氧胆酸  阿霉素  心肌保护  炎症  凋亡
收稿时间:2020/7/28 0:00:00
修稿时间:2020/8/21 0:00:00

Effects of Ursodeoxycholic Acid on Doxorubicin-induced Injury in H9c2 Cardiomyocytes and Its Mechanism
WANG Hao,XIA Wei-wei,LONG Guang-feng,YANG Da-heng,PEI Zhi-yin,CHEN Hong-bing.Effects of Ursodeoxycholic Acid on Doxorubicin-induced Injury in H9c2 Cardiomyocytes and Its Mechanism[J].Progress in Modern Biomedicine,2021(3):418-423.
Authors:WANG Hao  XIA Wei-wei  LONG Guang-feng  YANG Da-heng  PEI Zhi-yin  CHEN Hong-bing
Institution:(Department of Clinical Laboratory,Children's Hospital of Nanjing Medical University,Nanjing,Jiangsu,210008,China;Key Laboratory of Pediatrics,Nanjing Medical University,Nanjing,Jiangsu,210008,China)
Abstract:Objective: To investigate the effect of Ursodeoxycholic Acid(UDCA) on doxorubicin(DOX)-induced cardiotoxicity in H9 c2 cardiomyocytes and the mechanisms. Methods: The H9 c2 cardiomyocytes were treated with DOX with or without UDCA of different doses. The cell viability was measured by CCK-8 assay, and the inflammatory factors were examined by quantitative real-time polymerase chain reaction(qRT-PCR). As for apoptosis, Western blotting, qRT-PCR were used to analyze. Results: Compared with control group, the viability of H9 c2 cells, the anti-apoptotic protein Bcl2 were decreased(P<0.05). Additionally, the release of inflammatory factors(IL-1β, IL-6), apoptotic molecules(Bax and Cleaved Caspase3) was increased(P<0.05). Compared with DOX group, UDCA+DOX group restored the cell viability, ameliorated the release of inflammatory factors(IL-1β, IL-6), inhibited pro-apoptotic molecules(Bax and Cleaved Caspase3), promoted anti-apoptotic molecules Bcl2 as well(P<0.05). Conclusions: UDCA suppresses DOX-induced injury in H9 c2 cardiomyocytes by reducing inflammation and apoptosis, which provides a pivotal theoretical basis for the clinical application of UDCA in the prevention and treatment of DOX-induced cardiotoxicity.
Keywords:Ursodeoxycholic Acid (UDCA)  Doxorubicin (DOX)  Myocardium protection  Inflammation  Apoptosis
本文献已被 维普 等数据库收录!
点击此处可从《现代生物医学进展》浏览原始摘要信息
点击此处可从《现代生物医学进展》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号